Análisis del comportamiento del mercado farmacéutico privado ecuatoriano en el segmento de ventas de productos genéricos versus marca: período 2007 – 2013
Fecha
2015
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad de Guayaquil Facultad de Ciencias Administrativas
Resumen
El objetivo de este trabajo es determinar cómo las disposiciones gubernamentales del actual régimen han incidido en la venta de productos genéricos comparándolo con el original en el mercado privado farmacéutico ecuatoriano, por su constante crecimiento se escogió el segmento Inhibidores de la Angiotensina II, específicamente con el Valsartán en el período 2007- 2014. Además se espera que sea una guía en la decisión de otras empresas de ingresar o no más productos con el mismo principio activo en este segmento o en cualquier otro y la vez que permita una reacción oportuna y adecuada. En su primera parte se aborda la realidad del mercado farmacéutico mundial, latinoamericano y nacional. Se hace un análisis estructural del sector, y se identifica los factores del entorno general que van a afectar a las empresas. Y en la cadena de valores de este mercado se resume como en la actividad competitiva y globalizada está su principal característica. Se concluye el trabajo con un análisis de los reportes obtenidos por el Data Quest en el período establecido y cómo las unidades y valores de los productos en análisis han variado su comportamiento.
The purpose of this study is to determine how government provisions of the current regime have influenced the sale of generic products compared to the original in the Ecuadorian pharmaceutical private market, by steady growth the segment Inhibitors Angiotensin II was chosen specifically for the Valsartan in the period 2007 to 2014. It is also expected to be a guide in deciding other companies entering or more products with the same active ingredient in this segment or at any time and allow timely and adequate reaction. The first part of the reality of the world, Latin American and domestic pharmaceutical market is discussed. A structural analysis of the sector is made, and the overall environment factors that will affect companies identified. And in the value chain of this market is summarized as competitive and globalized activity is its main feature. Work with an analysis of the reports obtained by the Data Quest in the period established and how units and values of the products have changed their behavior analysis concludes.
The purpose of this study is to determine how government provisions of the current regime have influenced the sale of generic products compared to the original in the Ecuadorian pharmaceutical private market, by steady growth the segment Inhibitors Angiotensin II was chosen specifically for the Valsartan in the period 2007 to 2014. It is also expected to be a guide in deciding other companies entering or more products with the same active ingredient in this segment or at any time and allow timely and adequate reaction. The first part of the reality of the world, Latin American and domestic pharmaceutical market is discussed. A structural analysis of the sector is made, and the overall environment factors that will affect companies identified. And in the value chain of this market is summarized as competitive and globalized activity is its main feature. Work with an analysis of the reports obtained by the Data Quest in the period established and how units and values of the products have changed their behavior analysis concludes.
Descripción
Palabras clave
NORMAS GUBERNAMENTALES, MERCADO FARMACÉUTICO PRIVADO, CRECIMIENTO, OPORTUNIDADES